Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-16-001504
Filing Date
2016-06-13
Accepted
2016-06-13 16:21:59
Documents
2
Group Members
BIHUA CHENCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G a70174_sc13g.htm SC 13G 96907
2 JOINT FILING AGREEMENT exhibit1.htm EX-1 11974
  Complete submission text file 0000929638-16-001504.txt   110554
Mailing Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005
Business Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005 678-270-4005
Clearside Biomedical, Inc. (Subject) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89527 | Film No.: 161710955
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LLC (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G